Significance of thrombocytosis in patients with epithelial ovarian cancer

Am J Obstet Gynecol. 1994 Feb;170(2):549-54. doi: 10.1016/s0002-9378(94)70225-x.

Abstract

Objectives: Our objective was to determine the relevance of a preoperative platelet count in ovarian cancer. Special interest was directed to a possible prognostic significance of thrombocytosis in this disease.

Study design: Charts of 130 patients with epithelial ovarian cancer were reviewed retrospectively. Survival analyses were performed with the Kaplan-Meier method. Differences in survival were examined according to Mantel and Breslow. Platelet counts were furthermore correlated to other clinical parameters. For this purpose the Spearman rank test and a stepwise logistic regression model were used. Data comparison was accomplished with the Mann-Whitney U test and the chi 2 test.

Results: Prevalence of thrombocytosis was 38%. No differences in survival between patients with or without thrombocytosis was found. Volume of ascites and hemoglobin concentrations were independently associated with thrombocytosis (p = 0.002 and p = 0.004, respectively).

Conclusions: Thrombocytosis is not a useful prognostic factor in ovarian cancer. Elevated platelets are predominantly associated with the presence of ascites and marked anemia.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anemia / etiology
  • Ascites / etiology
  • Carcinoma / blood
  • Carcinoma / complications*
  • Carcinoma / mortality
  • Female
  • Humans
  • Logistic Models
  • Middle Aged
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / complications*
  • Ovarian Neoplasms / mortality
  • Platelet Count
  • Prognosis
  • Retrospective Studies
  • Survival Analysis
  • Thrombocytosis / etiology*